Loader

Pathways

PathWhiz ID Pathway Meta Data

PW145952

Pw145952 View Pathway
drug action

Tasimelteon Drug Metabolism Action Pathway

Homo sapiens

PW127587

Pw127587 View Pathway
drug action

Tasosartan Action Pathway

Homo sapiens
Tasosartan is a selective angiotensin II (AngII) receptor type 1 (AT1) inhibitor. It is used for the treatment of hypertension and heart failure. This drug causes the blockade of the renin-angiotensin-aldosterone system (RAAS) at the level of the AT1 receptor. Tasosartan is an antagonist of the AT1 receptors localize in the vascular muscles and the adrenal gland. This drug thus causes dilatation, reduced secretion of avsopressin (ADH), and reduced production and secretion of aldosterone.

PW123924

Pw123924 View Pathway
metabolic

Taurine & Hypotaurine Metabolism

Drosophila melanogaster
Taurine and hypotaurine are aminosulfinic acids. Taurine has many physiological functions as neuromodulators, membrane stabilizers, facilitator of ion transport and aiding auditory transduction. Hypotaurine has roles such as antioxidant and a protective agent. Taurine and hypotaurine are synthesized from L-cysteine. L-Cysteine is involved in cyanoacid metabolism and glutathione metabolism. L-Cysteine goes through redox reactions, elimination reactions and other metabolism pathways to eventually form taurine and hypotaurine. L-Cysteine is converted to cysteamine, which can then form hypotaurine through the enzyme cysteamine dioxygenase. L-Cysteine can also be converted to 3-sulfinoalanine through the enzyme cysteine dioxygenase. Hypotaurine can then be formed from the enzymes glutamate decarboxylase and sulfinoalanine decarboxylase acting on 3-sulfinoalanine. 3-sulfinoalanine can form taurine by first converting to L-cysteate. L-Cysteate is then metabolized to taurine via glutamate decarboxylase and sulfinoalanine decarboxylase. The hypotaurine formed in this pathway can be metabolised to taurine, then taurine is metabolised to 5-L-glutamyl-taurine by reacting with (5-L-glutamyl)-peptide via the enzyme gamma-glutamyltranspeptidase. Taurine can also undergo excretion from the organism.

PW002480

Pw002480 View Pathway
metabolic

Taurine and Hypotaurine Biosynthesis

Saccharomyces cerevisiae
The biosynthesis of taurine and hypotaurine is processed by the same protein, glutamate decarboxylase. Hypotaurine is produced by 3-sulfino-L-alanine reacting with glutamate decarboxylase resulting in the release of carbon dioxide and hypotaurine. Taurine is produced by L-cysteate reacting with a glutamate decarboxylase resulting in the release of Taurine and carbon dioxide

PW122344

Pw122344 View Pathway
metabolic

Taurine and Hypotaurine Metabolism

Drosophila melanogaster

PW122490

Pw122490 View Pathway
metabolic

Taurine and Hypotaurine Metabolism

Xenopus laevis

PW088233

Pw088233 View Pathway
metabolic

Taurine and Hypotaurine Metabolism

Bos taurus
There is an organic acid known as Taurine, which is a derivative product of sulfhydryl amino acid (which contains sulfur), as well as cysteine. The synthesis or metabolism in mammalian systems of this acid transpires within the pancreas in such a fashion that it utilizes a pathway known as the cysteine sulfinic acid pathway. To put this process in context, its occurrence is often seen in vivo, in hepatocytes, and is fundamental in the cyclical process of recovering bile acids from the intenstine, turning them back into salts and returning them to the bile. In essence the cysteine pathway induces a sulfhydryl group to be oxidized, creating cysteine sulfinic acid, by utilizing the appropriate enzymes (ie cysteine dioxygenase). This new acid undergoes decarboxylation creating a new compound: hypotaurine. This process goes on as Taurine now is subjected to conjugation vis a vis its amino terminal group. This includes acids such as chenodeoxycholic acid and cholic acid, and in turn the formation of bile salts occurs. Moreover, this entire process can be catalyzed via bile acid and a special amino acid N-acetyltransferase.

PW122491

Pw122491 View Pathway
metabolic

Taurine and Hypotaurine Metabolism

Danio rerio

PW064657

Pw064657 View Pathway
metabolic

Taurine and Hypotaurine Metabolism

Mus musculus
There is an organic acid known as Taurine, which is a derivative product of sulfhydryl amino acid (which contains sulfur), as well as cysteine. The synthesis or metabolism in mammalian systems of this acid transpires within the pancreas in such a fashion that it utilizes a pathway known as the cysteine sulfinic acid pathway. To put this process in context, its occurrence is often seen in vivo, in hepatocytes, and is fundamental in the cyclical process of recovering bile acids from the intenstine, turning them back into salts and returning them to the bile. In essence the cysteine pathway induces a sulfhydryl group to be oxidized, creating cysteine sulfinic acid, by utilizing the appropriate enzymes (ie cysteine dioxygenase). This new acid undergoes decarboxylation creating a new compound: hypotaurine. This process goes on as Taurine now is subjected to conjugation vis a vis its amino terminal group. This includes acids such as chenodeoxycholic acid and cholic acid, and in turn the formation of bile salts occurs. Moreover, this entire process can be catalyzed via bile acid and a special amino acid N-acetyltransferase.

PW088328

Pw088328 View Pathway
metabolic

Taurine and Hypotaurine Metabolism

Rattus norvegicus
There is an organic acid known as Taurine, which is a derivative product of sulfhydryl amino acid (which contains sulfur), as well as cysteine. The synthesis or metabolism in mammalian systems of this acid transpires within the pancreas in such a fashion that it utilizes a pathway known as the cysteine sulfinic acid pathway. To put this process in context, its occurrence is often seen in vivo, in hepatocytes, and is fundamental in the cyclical process of recovering bile acids from the intenstine, turning them back into salts and returning them to the bile. In essence the cysteine pathway induces a sulfhydryl group to be oxidized, creating cysteine sulfinic acid, by utilizing the appropriate enzymes (ie cysteine dioxygenase). This new acid undergoes decarboxylation creating a new compound: hypotaurine. This process goes on as Taurine now is subjected to conjugation vis a vis its amino terminal group. This includes acids such as chenodeoxycholic acid and cholic acid, and in turn the formation of bile salts occurs. Moreover, this entire process can be catalyzed via bile acid and a special amino acid N-acetyltransferase.